Sling Therapeutics

Clinical-stage biopharma developing linsitinib, an oral small-molecule IGF-1R inhibitor for thyroid eye disease, now in Phase 3.


This profile is unclaimed — do you work here? Claim it

Claim it →
Founded
—
Headcount
—
Open roles
0
Last raised
Series C

FUNDING

Capital raised


OPEN ROLES

Roles at Sling Therapeutics

Employbl doesn’t track Sling Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →


SIMILAR COMPANIES

Companies like Sling Therapeutics

Picked from companies in the same industries as Sling Therapeutics, ranked by funding-stage adjacency and hiring activity.

Create free account to see all similar companies →